{
    "organizations": [],
    "uuid": "a9764601478fefae218c994fb98a455074818537",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-reneuron-group-says-initial-cancer/brief-reneuron-group-says-initial-cancer-clinical-trial-application-planned-for-2019-idUSFWN1R802I",
    "ord_in_thread": 0,
    "title": "BRIEF-Reneuron Group Says Initial Cancer Clinical Trial Application Planned For 2019",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Reneuron Group Plc:\n* RENEURON GROUP PLC - PHASE I/II STUDY TO BE EXPANDED TO TARGET PATIENTS WITH LESS IMPAIRED VISION AHEAD OF FUTURE PHASE IIB STUDY\n* RENEURON GROUP PLC - TOP LINE PHASE I/II DATA NOW EXPECTED IN H1 2019\n* RENEURON GROUP PLC - INITIAL CLINICAL TRIAL APPLICATION PLANNED FOR 2019 IN CANCER\n* RENEURON GROUP PLC - EXPECT SHORT TERM READ-OUTS FROM ONGOING PHASE I/II CLINICAL TRIAL LATER THAN ORIGINALLY PLANNED, IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-26T14:37:00.000+03:00",
    "crawled": "2018-03-27T11:37:35.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "reneuron",
        "group",
        "plc",
        "reneuron",
        "group",
        "plc",
        "phase",
        "study",
        "expanded",
        "target",
        "patient",
        "less",
        "impaired",
        "vision",
        "ahead",
        "future",
        "phase",
        "iib",
        "study",
        "reneuron",
        "group",
        "plc",
        "top",
        "line",
        "phase",
        "data",
        "expected",
        "h1",
        "reneuron",
        "group",
        "plc",
        "initial",
        "clinical",
        "trial",
        "application",
        "planned",
        "cancer",
        "reneuron",
        "group",
        "plc",
        "expect",
        "short",
        "term",
        "ongoing",
        "phase",
        "clinical",
        "trial",
        "later",
        "originally",
        "planned",
        "first",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}